Icahn School of Medicine at Mount Sinai and Cooper Union Announce Student Exchange and Collaborative Research Program
Agreement will enrich academic experience
The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS) and the Albert Nerken School of Engineering at The Cooper Union for the Advancement of Science and Art today announced an academic agreement that includes collaboration on research and academic programs, effective immediately.
Through this agreement, matriculated ISMMS doctoral students and Cooper Union students will each be able to take courses at the other institution, with the first registration opportunity in November 2018 for courses in 2019. Students will require approvals by course directors and other relevant officials at the home and host institution, and will be required to meet all of the host institution’s academic and institutional standards.
“This collaboration holds great promise for enriching the academic experiences of our students and those at Cooper Union,” said Marta Filizola, PhD, Dean of the Graduate School of Biomedical Sciences and Sharon and Frederick Klingenstein/Nathan Kase, M.D. Professor of Pharmacological Sciences at ISMMS. “Both institutions are committed to a culture of innovation in research and education, and we are excited to offer this unique experience for students.”
“This exchange is great for our students and it's great for New York City,” said Richard Stock, Dean of the Albert Nerken School of Engineering. Referring to Cooper-Union’s commitment to science, technology, engineering, and math, known as STEM, Stock continued.
“By opening up specialized biomedical labs and courses to our engineering students, while offering our world-class engineering resources to ISMMS, we continue to bolster this city as a major location for STEM research.”
Through this collaboration, students at ISMMS and Cooper Union will also be eligible to participate in joint research at each institution. The range of research areas will include: bioengineering, biomedical engineering, proteomics, biomechanics, microbiome, and biomedical computational projects. ISMMS and Cooper Union faculty will jointly advise on collaborative research projects, with the home institution advisor retaining primary supervisory and grading responsibility for the student. Cooper Union faculty will conduct annual workshops on engineering concepts, while ISMMS faculty will present on biomedical concepts.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases